← All peptidesDelivery format
Topical peptides
Peptides in serums, creams, and patches you apply to skin
Topical peptides occupy the regulatory sweet spot: classified as cosmetics in most jurisdictions, they bypass the harshest YMYL filters that throttle injectable peptide content. The clinical evidence base is also strongest here — Matrixyl 3000, Argireline, GHK-Cu, and SNAP-8 each have multiple split-face human trials documenting wrinkle reduction, collagen synthesis, and barrier repair. This is the comprehensive index of every peptide we cover in topical form, with stacking compatibility notes and 2026 evidence tiers.
5 peptides we cover in this format
Ranked by 30-day query volume
Argireline
+11%Acetyl hexapeptide-8 — 'Botox in a bottle' topical peptide. SNAP-25 inhibition mechanism, different molecular target than botulinum toxin but adjacent expression-line softening effect. Modest RCT evidence (Blanes-Mira 2002, Wang 2013). Topical-only.
Skin / anti-aging85K/moCosmeticBPC-157
+42%Pentadecapeptide derived from a human gastric-juice protein, extensively studied in rodent models for tendon, ligament, and gut-tissue healing via angiogenesis and fibroblast-migration mechanisms. Human evidence base remains thin. FDA Interim Category 2 pending July 2026 PCAC review.
RecoveryRecovery pillar48.2K/moCat 2 → reviewWADA prohibitedMatrixyl 3000
+6%Combination of two palmitoylated peptides that signal collagen and fibronectin synthesis in dermal fibroblasts. Best clinical evidence among topical anti-aging peptides — multiple split-face trials show measurable wrinkle reduction over 8-12 weeks. Often layered over GHK-Cu in technical stacks.
Skin / anti-aging42K/moCosmeticGHK-Cu
+9%Copper-binding tripeptide (Gly-His-Lys + Cu) with decades of cosmetic-industry research. Documented mechanism on collagen synthesis, matrix-metalloproteinase modulation, and antioxidant defense. Widely available as cosmetic-grade topical under standard cosmetic regulation.
Skin / anti-agingSkin & Anti-Aging pillar14.2K/moCosmeticWADA prohibitedSNAP-8
+8%8-aa elongation of Argireline's mechanism with stronger SNARE-complex inhibition. Marketed as more potent than Argireline at same concentration. Limited independent peer-reviewed studies; manufacturer (Lipotec) data shows ~30% expression-line reduction over 4 weeks. Topical only.
Skin / anti-aging14K/moCosmetic
New to peptides?
Read the medical-reviewer-signed primer that explains how peptide therapy actually works — what the evidence says, what it doesn't, and how to read the regulatory landscape.
Read: What are peptides?